113 related articles for article (PubMed ID: 1963583)
1. Deregulated c-myc gene expression and persistence of EBV are not sufficient to maintain the malignant phenotype in Burkitt's lymphoma x B-lymphoblastoid hybrid cells.
Wolf J; Pawlita M; Bullerdiek J; zur Hausen H
Curr Top Microbiol Immunol; 1990; 166():333-6. PubMed ID: 1963583
[No Abstract] [Full Text] [Related]
2. Suppression of the malignant phenotype in somatic cell hybrids between Burkitt's lymphoma cells and Epstein-Barr virus-immortalized lymphoblastoid cells despite deregulated c-myc expression.
Wolf J; Pawlita M; Bullerdiek J; zur Hausen H
Cancer Res; 1990 May; 50(10):3095-100. PubMed ID: 2159373
[TBL] [Abstract][Full Text] [Related]
3. Regressing nude mouse grafts of Burkitt's lymphoma x lymphoblastoid cell hybrids show deregulation of the c-myc gene and expression of the EBV latent membrane protein.
Wolf J; Klevenz B; Pawlita M; Komitowski D; Moldenhauer G; zur Hausen H
Int J Cancer; 1991 Jan; 47(1):99-104. PubMed ID: 1702406
[TBL] [Abstract][Full Text] [Related]
4. Epstein-Barr virus and Burkitt's lymphoma.
Magrath I; Jain V; Bhatia K
Semin Cancer Biol; 1992 Oct; 3(5):285-95. PubMed ID: 1335792
[TBL] [Abstract][Full Text] [Related]
5. EBNA2 and c-myc in B cell immortalization by Epstein-Barr virus and in the pathogenesis of Burkitt's lymphoma.
Zimber-Strobl U; Strobl L; Höfelmayr H; Kempkes B; Staege MS; Laux G; Christoph B; Polack A; Bornkamm GW
Curr Top Microbiol Immunol; 1999; 246():315-20; discussion 321. PubMed ID: 10396071
[No Abstract] [Full Text] [Related]
6. The etiology of Burkitt's lymphoma and the history of the shaken dogmas.
de Thé G
Blood Cells; 1993; 19(3):667-73; discussion 674-5. PubMed ID: 8018947
[TBL] [Abstract][Full Text] [Related]
7. Activation of Epstein-Barr virus in hybrid cells.
Tsang KY; Hann WD
J Natl Cancer Inst; 1977 May; 58(5):1295-301. PubMed ID: 192898
[TBL] [Abstract][Full Text] [Related]
8. Cytogenetic rearrangement of C-MYC oncogene occurs prior to infection with Epstein-Barr virus in the monoclonal malignant B cells from an AIDS patient.
Roncella S; Di Celle PF; Cutrona G; Carbone A; Sessarego M; Landonio G; Foà R; Rowe M; Ferrarini M
Leuk Lymphoma; 1993 Jan; 9(1-2):157-64. PubMed ID: 8386576
[TBL] [Abstract][Full Text] [Related]
9. Transcription of Epstein-Barr virus genomes in human lymphoblastoid cells and in somatic-cell hybrids of Burkitt's lymphoma.
Nonoyama M; Tanaka A; Silver S; Glaser R
IARC Sci Publ (1971); 1978; (24 Pt 1):559-63. PubMed ID: 221360
[TBL] [Abstract][Full Text] [Related]
10. Stable nontumorigenic phenotype of somatic cell hybrids between malignant Burkitt's lymphoma cells and autologous EBV-immortalized B cells despite induction of chromosomal breakage and loss.
Jox A; Taquia E; Vockerodt M; Draube A; Pawlita M; Möller P; Bullerdiek J; Diehl V; Wolf J
Cancer Res; 1998 Nov; 58(21):4930-9. PubMed ID: 9810002
[TBL] [Abstract][Full Text] [Related]
11. Establishment of somatic hybrid cell clones from rat embryonic fibroblast cells with Burkitt's lymphoblastoid cells using polyethylene glycol.
Darai G; Doerr HW; Matz B; Flügel RM; Zentgraf H; Munk K
IARC Sci Publ (1971); 1978; (24 Pt 1):571-6. PubMed ID: 221362
[No Abstract] [Full Text] [Related]
12. Phenotypic and cytogenetic characteristics of human B-lymphoid cell lines and their relevance for the etiology of Burkitt's lymphoma.
Nilsson K; Klein G
Adv Cancer Res; 1982; 37():319-80. PubMed ID: 6305160
[No Abstract] [Full Text] [Related]
13. The Epstein-Barr Virus (EBV) in Burkitt's lymphoma and nasopharyngeal carcinoma.
Henle W; Henle G
Ann Clin Lab Sci; 1974; 4(2):109-14. PubMed ID: 4362218
[No Abstract] [Full Text] [Related]
14. Epstein-Barr virus-regulation studies on somatic-cell hybrids derived from the fusion of Burkitt's lymphoma and nasopharyngeal carcinoma cells with human or mouse partners.
Klein G
IARC Sci Publ (1971); 1978; (20):369-76. PubMed ID: 215519
[No Abstract] [Full Text] [Related]
15. Analysis of the tumorigenic potential of common marmoset lymphoblastoid cells expressing a constitutively activated c-myc gene.
Hotchin NA; Wedderburn N; Roberts I; Thomas JA; Bungey JA; Naylor B; Crawford DH
Br J Cancer; 1993 May; 67(5):926-32. PubMed ID: 8388232
[TBL] [Abstract][Full Text] [Related]
16. Immune escape by Epstein-Barr virus (EBV) carrying Burkitt's lymphoma: in vitro reconstitution of sensitivity to EBV-specific cytotoxic T cells.
Masucci MG; Zhang QJ; Gavioli R; De Campos-Lima PO; Murray RJ; Brooks J; Griffin H; Ploegh H; Rickinson AB
Int Immunol; 1992 Nov; 4(11):1283-92. PubMed ID: 1282031
[TBL] [Abstract][Full Text] [Related]
17. Deregulated c-myc expression in Epstein-Barr-virus-immortalized B-cells induces altered growth properties and surface phenotype but not tumorigenicity.
Hotchin NA; Allday MJ; Crawford DH
Int J Cancer; 1990 Mar; 45(3):566-71. PubMed ID: 2155186
[TBL] [Abstract][Full Text] [Related]
18. Epstein-Barr virus-enhancing plant promoters in east Africa.
Mizuno F; Osato T; Imai S; Koizumi S; Aya T; Kinoshita T; Hirai N; Hirota M; Ohigashi H; Koshimizu K
AIDS Res; 1986 Dec; 2 Suppl 1():S151-5. PubMed ID: 3030344
[TBL] [Abstract][Full Text] [Related]
19. Characterization and comparison of two newly established Epstein-Barr virus (EBV)-negative and EBV-positive Burkitt's lymphoma cell lines. EBV-negative cell line with a low level of expression of ICAM-1 molecule and EBV-positive cell line with a high level of expression of ICAM-1 molecule.
Abe M; Tasaki K; Tominaga K; Fukuhara S; Imai S; Osato T; Wakasa H
Cancer; 1992 Feb; 69(3):763-71. PubMed ID: 1309680
[TBL] [Abstract][Full Text] [Related]
20. Local growth of a Burkitt's lymphoma versus disseminated invasive growth of the autologous EBV-immortalized lymphoblastoid cells and their somatic cell hybrids in SCID mice.
Walter J; Möller P; Moldenhauer G; Schirrmacher V; Pawlita M; Wolf J
Int J Cancer; 1992 Jan; 50(2):265-73. PubMed ID: 1309726
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
